Vascular Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Vascular Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients (NCT02251067) | Vascular Pharmaceuticals, Inc. | 2014-09-01 |
Track Vascular Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.